Search

everythinglearnresearchcommunity

for

Search:↓

People with Lichen sclerosus are more likely to have skin conditions like vitiligo and alopecia areata, heart disease risks, and other health issues. They should be checked for these, but screening plans shouldn't differ based on gender due to lack of data.

Tinea capitis is a fungal infection of the scalp that mainly affects children and can cause symptoms from mild itching to severe inflammation.

A 69-year-old woman has a fast-growing hand lesion that didn't improve with salicylic acid.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Low-level light therapy may reduce hair loss and improve hair quality but it's unclear who benefits most.

Lichen planus commonly affects middle-aged adults, often involves limbs and mucosal areas, and can be linked to immune diseases.

Type 1 diabetes may cause certain autoimmune diseases in Europeans.

Hair loss can be treated with medications like finasteride and surgical methods like hair transplants.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

People with rheumatoid arthritis have a higher risk of developing alopecia areata.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Alopecia areata is increasing globally, with disparities needing better prevention and support.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

SQSTM1 gene issues may increase the risk of alopecia areata.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.